DBS Keeps Their Buy Rating on Shandong Weigao Group Medical Polymer Co (SHWGF)
Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$6.29 From HK$8.45, Keeps at Buy
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Shandong Weigao Group Medical Polymer Co (OtherSHWGF) and Cormedix (CRMD)
Jefferies Sticks to Its Buy Rating for Shandong Weigao Group Medical Polymer Co (SHWGF)
Shandong Weigao Group Medical Polymer Co (SHWGF) Gets a Buy From Jefferies
Jefferies Reaffirms Their Buy Rating on Shandong Weigao Group Medical Polymer Co (SHWGF)
Jefferies Sticks to Its Buy Rating for Shandong Weigao Group Medical Polymer Co (SHWGF)
Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$14.79 From HK$15.90, Keeps at Buy
Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$12.55 From HK$11.87, Keeps at Buy
No Data
No Data